Concierge Cardiology · Post-Surgical

Post-Valve Surgery Monitoring.

Personalized, physician-led post-valve surgery monitoring with direct access to your cardiology team. Proactive monitoring. Faster interventions. Better outcomes.

Serrie Lico, MD, Chief Medical Officer

TAVR procedures surpassed SAVR in 2019, now exceeding 80,000/year in the U.S.

Tavr Growth

Bioprosthetic valves typically last 10-20 years before requiring reintervention

Bioprosthetic Life

TTR > 75% reduces thromboembolic events by 60% in mechanical valve patients

Anticoag Target

Overview

Understanding post-valve surgery monitoring.

Valve surgery — whether surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR), mitral valve repair or replacement, or tricuspid valve intervention — has experienced transformative advances over the past decade. The 2020 ACC/AHA Valvular Heart Disease guidelines recommend lifelong surveillance for all patients with prosthetic heart valves, as both mechanical and bioprosthetic valves carry risks that evolve over time. Mechanical valves require meticulous anticoagulation management with warfarin, targeting specific INR ranges based on valve position and patient risk factors. Even small deviations from therapeutic range increase the risk of thromboembolism (subtherapeutic INR) or major bleeding (supratherapeutic INR). Bioprosthetic valves, while not requiring long-term anticoagulation, have a finite lifespan — structural valve degeneration (SVD) typically begins 8-15 years after implantation, and early detection through serial echocardiography allows planned valve-in-valve intervention rather than emergency surgery. Our concierge post-valve program provides structured echocardiographic surveillance at guideline-directed intervals, precision anticoagulation management for mechanical valves, endocarditis prevention education, and proactive detection of valve dysfunction — keeping patients safe for years and decades after their procedure.

Why Concierge

Why concierge cardiology for this condition.

Post-valve surgery patients require lifelong specialized monitoring that is difficult to deliver in a standard cardiology practice seeing 25+ patients per day. INR management for mechanical valves demands frequent testing and rapid dose adjustments — a single missed result can mean the difference between therapeutic anticoagulation and a valve thrombosis. Bioprosthetic valve patients need serial echocardiography at precise intervals to detect the earliest signs of structural deterioration. Concierge care provides weekly or biweekly INR monitoring with same-day warfarin adjustment, scheduled echocardiographic surveillance per ACC/AHA guidelines (baseline post-op, 1 year, then annually or with any symptom change), immediate access for concerning symptoms like new dyspnea, syncope, or fever (possible endocarditis), and coordination between the surgical team and managing cardiologist. This model prevents the surveillance gaps that lead to late detection of paravalvular leak, patient-prosthesis mismatch, and structural valve degeneration.

What we monitor.

Serial transthoracic echocardiography: prosthetic valve gradients, effective orifice area, regurgitation severity

INR monitoring (mechanical valves): target 2.5-3.5 for mitral, 2.0-3.0 for aortic mechanical prostheses

LV remodeling: LVEF, LV mass regression, chamber dimensions post-valve intervention

Hemolysis markers (LDH, haptoglobin, reticulocyte count) for paravalvular leak detection

Infectious endocarditis risk: dental health coordination, blood cultures for unexplained fever

New or worsening conduction abnormalities (especially post-TAVR — 10-20% new LBBB incidence)

Functional status: NYHA class, exercise capacity, and symptom progression

Our management approach.

Echocardiographic surveillance per 2020 ACC/AHA VHD guidelines: post-op baseline, annual thereafter, and with any symptom change

Precision INR management for mechanical valves with home INR testing devices and same-day dose adjustments

Antiplatelet therapy optimization for bioprosthetic valves (aspirin for 3-6 months post-SAVR, longer post-TAVR)

Endocarditis prophylaxis education and dental care coordination (AHA guidelines for prosthetic valve patients)

Structural valve degeneration surveillance with early identification for valve-in-valve TAVR candidacy

Post-TAVR pacemaker monitoring for patients who develop conduction disease

Heart failure prevention: volume management, afterload optimization, and functional assessment

Expected outcomes.

Time in therapeutic INR range (TTR) exceeding 75% for mechanical valve patients (vs. 55-65% national average)

Early detection of structural valve degeneration enabling planned valve-in-valve procedures instead of emergency surgery

Near-zero rate of prosthetic valve endocarditis through rigorous prevention protocols

Sustained LV reverse remodeling with LVEF improvement documented in 80%+ of aortic stenosis patients post-intervention

Reduction in valve-related emergency department visits by 50% through proactive symptom management

Related concierge services.

Post-CABG Long-Term Care

Post-Stent & Post-PCI Care

Cardiac Rehabilitation & Recovery

Ensure the longevity of your valve surgery with dedicated concierge monitoring and expert follow-up care.

Direct physician access, proactive monitoring, and personalized care plans. Concierge cardiology starting at $295/month.

View Concierge Plans About Concierge Cardiology